N-051
Nalbuphine hydrochloride solution
1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
grade
certified reference material
Quality Level
form
liquid
feature
Snap-N-Spike®/Snap-N-Shoot®
packaging
ampule of 1 mL
manufacturer/tradename
Cerilliant®
concentration
1.0 mg/mL in methanol (as free base)
technique(s)
gas chromatography (GC): suitable, liquid chromatography (LC): suitable
application(s)
forensics and toxicology
format
single component solution
storage temp.
−20°C
SMILES string
Cl.O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC6CCC6)c45
InChI
1S/C21H27NO4.ClH/c23-14-5-4-13-10-16-21(25)7-6-15(24)19-20(21,17(13)18(14)26-19)8-9-22(16)11-12-2-1-3-12;/h4-5,12,15-16,19,23-25H,1-3,6-11H2;1H/t15-,16+,19-,20-,21+;/m0./s1
InChI key
YZLZPSJXMWGIFH-BCXQGASESA-N
Gene Information
human ... OPRD1(4985), OPRK1(4986), OPRM1(4988)
General description
A Snap-N-Spike® reference solution applicable for use in urine drug testing, pain prescription monitoring, clinical toxicology, forensic analysis, or pharmaceutical research by LC-MS/MS or GC/MS. Nalbuphine is a semisynthetic opioid analgesic sold under the trade name Nubain®. This painkiller is prescribed for the relief of moderate to severe pain.
Legal Information
CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Nubain is a registered trademark of Endo Pharmaceuticals Inc.
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Supply conditions do not apply to the regions and states of Brazil: North, Northeast, Mato Grosso do Sul, Mato Grosso, and Rio Grande do Sul.
signalword
Danger
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
target_organs
Eyes
存储类别
3 - Flammable liquids
wgk
WGK 2
flash_point_f
49.5 °F - closed cup
flash_point_c
9.7 °C - closed cup
法规信息
监管及禁止进口产品
此项目有
Vaginal delivery in a parturient excessively anticoagulated with fondaparinux.
N Hime et al.
International journal of obstetric anesthesia, 21(4), 385-387 (2012-08-25)
Anesteziologiia i reanimatologiia, (1)(1), 33-36 (2012-06-19)
We studied the changes in central and peripheral hemodynamic parameters under combined nubaine anesthesia during surgical interventions in children. The study was carried out at the stages of operation and anesthesia in 64 children at the age from 2 to
Vilnis Silins et al.
Paediatric anaesthesia, 22(3), 230-238 (2011-11-22)
Herniorraphy is a common surgical intervention in infants, particularly in those born prematurely. Prematurity and perioperative sedation have been shown to be risk factors for postoperative apnea. However, their influence upon PACU stay duration has not been evaluated. The goal
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| N-051-1ML | 04061834081685 |